Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
04/2005
04/13/2005CN1605629A Non-structural protein gene 3ABC of foot-and-mouth disease virus and its preparation and use
04/13/2005CN1605591A Labelled molecule capable of identifying reactive astrocytes and use thereof
04/13/2005CN1605589A PC-1 gene promoter and its application
04/12/2005US6878860 Comprises antisense nucleotides sequences transformed and expressed in tomato for controlling flowering; gene expression inhibition and tissue engineering
04/12/2005US6878814 Colorimetric analysis
04/12/2005US6878804 Coupling a solid support derived from polystyrene crosslinked with divinylbenzene which is functionalized by 2-chlrotrityl linker with an N-protected derivatives of preferential amino acid
04/12/2005US6878533 Enzymatic activity for use in the biosynthesis of lysine for use in foods
04/12/2005US6878519 DNA probes for specific genes of anthrax
04/12/2005US6878517 Multispecies food testing and characterization organoleptic properties
04/12/2005CA2417135C Chimeric pre-activated transcription factors
04/12/2005CA2086672C Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
04/07/2005WO2005031350A2 Human protein acyl transferases and methods of uses therefor
04/07/2005WO2005031005A2 Compositions, methods and kits for determining the presence of trichomonas vaginalis in a test sample
04/07/2005WO2005031003A1 Mutations in wnt-frizzled signaling pathways associated with osteoarthritis
04/07/2005WO2005031002A2 Synthetic lethal screen using rna interference
04/07/2005WO2005030987A1 Partially double-stranded hairpin oligonucleotides immobilizable via the looped end and comprising a restriction site
04/07/2005WO2005030984A2 Method for small volume nucleic acid synthesis
04/07/2005WO2005030982A2 Coordinated decrease and increase of gene expression of more than one gene using transgenic constructs
04/07/2005WO2005030981A2 Homogeneous populations of molecules
04/07/2005WO2005030967A2 Crop plant cystatin proteinase inhibitors and methods of use
04/07/2005WO2005030966A2 Regulation of plant biomass and stress tolerance
04/07/2005WO2005030930A2 Variants of cyan fluorescent protein with improved fluorescent properties
04/07/2005WO2005030929A2 Polymeric nucleic acid hybridization probes
04/07/2005WO2005030928A2 PORCINE INVARIANT CHAIN PROTEIN, FULL LENGTH cDNA, GENOMIC ORGANIZATION, AND REGULATORY REGION
04/07/2005WO2005030799A1 Antisense compound and method for selectively killing activated t cells
04/07/2005WO2005030793A2 Antibodies which bind human cxcr3
04/07/2005WO2005030789A1 Adrenergic receptor snp for improved milking characteristics
04/07/2005WO2005030787A2 Oligonucleotide compositions and methods for treating disease including inflammatory conditions
04/07/2005WO2005030139A2 Seneca valley virus based compositions and methods for treating disease
04/07/2005WO2005030027A2 Salmonella detection identification
04/07/2005WO2005012351A8 Novel functions for decay accelerating factor (daf) in inflammation
04/07/2005WO2004102152A3 Improved porous device
04/07/2005WO2004096976A3 Spex compositions and methods of use
04/07/2005WO2004081224A3 Reca-assisted allele specific oligonucleotide extension method
04/07/2005WO2004074446A3 Parkin interacting polypeptides and methods of use
04/07/2005WO2004052301A3 Modulation of matrix metalloproteinase 11 expression
04/07/2005WO2004046069A3 Adrenergic receptors
04/07/2005WO2004044133A3 Modified oligonucleotides for use in rna interference
04/07/2005WO2004043978A3 2'-methoxy substituted oligomeric compounds and compositions for use in gene modulations
04/07/2005WO2003093452A3 Variants of nedd4l associated with hypertension and viral budding
04/07/2005US20050076411 Promoters functional in plant plastids
04/07/2005US20050076406 Plant-derived resistance gene
04/07/2005US20050075493 Flea synaptic vesicle nucleic acid molecules, proteins and uses thereof
04/07/2005US20050075492 Methods and products for expression of micro RNAs
04/07/2005US20050075491 Conjugating oligonucleotide with 3-substituted pyrazolo(3,4-d)pyrimidines and/or 5-substituted pyrimidine minor groove binder
04/07/2005US20050075490 Chloral-free DCA in oligonucleotide synthesis
04/07/2005US20050075307 Modulation of aminopeptidase N expression
04/07/2005US20050074879 Antisense oligonucleotide modulation of STAT3 expression
04/07/2005US20050074862 Polynucleotides encoding defense responde proteins
04/07/2005US20050074846 Per-arent-sim (PAS) interaction domain comprising human ether-a-go-go related gene (HERG) sequences for use as tool in treatment and prevention of oxidative damage to cardiovascular system
04/07/2005US20050074843 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
04/07/2005US20050074842 Membrane protein for use as tools in generation of vaccine; medical diagnosic and drug screening tools
04/07/2005US20050074838 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
04/07/2005US20050074837 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/07/2005US20050074801 Chimeric oligomeric compounds comprising alternating regions of northern and southern conformational geometry
04/07/2005US20050074796 Comprises benzazolium, pyridinium, or quinolinium connected by methine bridge; reporter molecules for detection of RNA in presence of DNA; solid phase synthesis; kits
04/07/2005US20050074794 labeling proteins and other molecules such as lipid and carbohydrates in different samples, then combining these samples for concurrent analysis, for reliable qualitative and quantitative comparison between the samples
04/07/2005US20050074781 Nucleic acid braided J-probes
04/07/2005US20050074777 Novel cell-surface estrogen receptor and related compositions and methods
04/07/2005US20050074773 Methods for diagnosing and treatment of conditions that alter phosphate transport in mammals
04/07/2005US20050074771 For attachment to steroids, reporter molecules, reporter enzymes, lipophilic molecules, peptides or proteins; for detecting RNA in samples
04/07/2005US20050074760 Enzymatic nucleic acids containing 5'-and/or 3'-cap structures
04/07/2005US20050074755 Nucleotide sequences coding mutator locus gene for use in diagnosis, prevention and treatment of cell proliferative disorders
04/07/2005US20050074753 Contains modified ribose rings within RNA; solid phase synthesis; kits
04/07/2005US20050074748 Bioreactive agents
04/07/2005US20050074478 Attachment of molecules to surfaces
04/07/2005CA2707765A1 Compositions, methods and kits for determining the presence of trichomonas vaginalis in a test sample
04/07/2005CA2540177A1 Seneca valley virus based compositions and methods for treating disease
04/07/2005CA2540049A1 Coordinated decrease and increase of gene expression of more than one gene using transgenic constructs
04/07/2005CA2539972A1 Antisense compound and method for selectively killing activated t cells
04/07/2005CA2539914A1 Small molecule compositions and methods for increasing drug efficiency using compositions thereof
04/07/2005CA2539752A1 Oligonucleotide compositions and methods for treating disease including inflammatory conditions
04/07/2005CA2539651A1 Synthetic lethal screen using rna interference
04/07/2005CA2539551A1 Adrenergic receptor snp for improved milking characteristics
04/06/2005EP1520860A2 Recombinant protein PilC, method for its production and use thereof
04/06/2005EP1520040A2 Microarrays displaying encoded molecules
04/06/2005EP1520030A1 Microorganisms and processes for enhanced production of pantothenate
04/06/2005EP1519941A2 A method of cleaving labile functional groups from chemical compounds
04/06/2005EP1326983B1 Gene cluster for ramoplanin biosynthesis
04/06/2005EP1278761B1 MODULATION OF OLIGONUCLEOTIDE CpG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES
04/06/2005EP0748219B1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
04/06/2005CN1603346A Protein, products containing same, and their use in diagnosis, treatment and /or prevention of SARS related disease
04/06/2005CN1603341A Human calcium ion / calmodulin deopendent protein kinase II inhibitory protein alpha, its coded sequence and use
04/06/2005CN1603332A Osmoregulatory gene and protein and their preparation method and use
04/06/2005CN1602958A A and O type gene engineering bivalent polypeptide vaccine of livestock foot-and-mouth disease virus and its preparation process
04/05/2005US6875859 Heterocyclic compounds and their use in the detection of nucleic acids
04/05/2005US6875858 Target nucleic acid is brought into contact with at least one functionalized nucleotide (a methylketone functionality) under suitabl conditions to produce a functionalized polynucleotide, labeling the product with a labeling reagent
04/05/2005US6875857 Composition for use in the extraction of preferential nucleotide sequences from cells
04/05/2005US6875850 Reagent for labelling nucleic acids
04/05/2005US6875750 Methylation of target compound using methyltransferase
04/05/2005US6875593 Oligomers capable of forming triplexes with various target sequences such as virus or oncogene sequences by coupling into major groove of target DNA duplex or forming duplexes by binding to single-stranded DNA or RNA encoded by target genes
04/05/2005US6875587 Human protease inhibitor and polynucleotides encoding the same
04/05/2005US6875576 Detection of modulators of receptor binding activity; obtain sample containing receptor, incubate with modulator, monitor adjustment of binding activity of receptor
04/05/2005CA2138240C Process for the preparation of polynucleotides on a solid substrate and device used therefore
03/2005
03/31/2005WO2005028665A2 Campylobacter polypeptides and methods of use
03/31/2005WO2005028649A1 RNA INTERFERENCE MEDIATED INHIBITION OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
03/31/2005WO2005028633A2 Modulation of rankl expression
03/31/2005WO2005028625A2 Consensus/ancestral immunogens
03/31/2005WO2005028617A2 Antisense inhibition of laminin-8 expression to inhibit human gliomas
03/31/2005WO2005028615A2 Methods and compositions for detecting promoter activity and expressing fusion proteins